Pfizer Ltd

Muthoot Finance Ltd, Brigade Enterprises Ltd, Authum Investment & Infrastructure Ltd, Astrazeneca Pharma India Ltd are among the other stocks to see a surge in volumes on NSE today, 14 August 2025.Pfizer Ltd clocked volume of 3.71 lakh shares by 14:14 IST on NSE, a 20.89 times surge over two-week average daily volume of 17752 shares. The stock gained 4.94% to Rs.5,359.50. Volumes stood at 15634 shares in the last session.Muthoot Finance Ltd registered volume of 76.89 lakh shares by 14:14 IST on NSE, a 19.73 fold spurt over two-week average daily volume of 3.90 lakh shares. The stock rose 9.80% to Rs.2,755.90. Volumes stood at 4.88 lakh shares in the last session.Brigade Enterprises Ltd witnessed volume of 26.75 lakh shares by 14:14 IST on NSE, a 11.69 times surge over two-week average daily volume of 2.29 lakh shares. The stock dropped 4.05% to Rs.927.10. Volumes stood at 1.76 lakh shares in the last session.Authum Investment & Infrastructure Ltd recorded volume of 9.86 lakh shares by 14:14 IST on NSE, a 7.26 times surge over two-week average daily volume of 1.36 lakh shares. The stock lost 3.33% to Rs.2,888.00. Volumes stood at 2.2 lakh shares in the last session.Astrazeneca Pharma India Ltd saw volume of 98300 shares by 14:14 IST on NSE, a 7.14 fold spurt over two-week average daily volume of 13759 shares. The stock increased 1.82% to Rs.8,570.00. Volumes stood at 34709 shares in the last session.Powered by Capital Market - Live

On a standalone basis, net profit rose 27.23% year-on-year to Rs 191.75 crore in Q1 FY26 from Rs 150.71 crore in Q1 FY25, but fell 3.3% sequentially from adjusted net profit of Rs 198.33 crore in Q4 FY25. Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs 591.91 crore in the March quarter. Profit before tax and exceptional items stood at Rs 259.53 crore in Q1 FY26, up 28.09% YoY and up 2.59% from Rs 252.99 crore in Q4 FY25. Total expenditure rose 1.99% YoY to Rs 393.03 crore from Rs 385.37 crore and was up 7.86% sequentially from Rs 364.41 crore. Cost of material consumed jumped 53.60% YoY to Rs 88.69 crore in Q1 FY26. Pfizer is one of the world's leading pharmaceutical companies, specialising in four key business categories ' vaccines, hospitals, internal medicine, and inflammation & immunology. Powered by Capital Market - Live

Net profit of Pfizer rose 27.23% to Rs 191.75 crore in the quarter ended June 2025 as against Rs 150.71 crore during the previous quarter ended June 2024. Sales rose 7.14% to Rs 603.05 crore in the quarter ended June 2025 as against Rs 562.86 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales603.05562.86 7 OPM %34.8331.53 - PBDT273.94217.22 26 PBT259.53202.62 28 NP191.75150.71 27 Powered by Capital Market - Live

Pfizer will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

Pfizer Ltd rose 6.26% today to trade at Rs 5689.95. The BSE Healthcare index is up 0.15% to quote at 45404.45. The index is up 3.16 % over last one month. Among the other constituents of the index, Sanofi Consumer Healthcare India Ltd increased 4.43% and Vimta Labs Ltd added 2.26% on the day. The BSE Healthcare index went up 13.01 % over last one year compared to the 0.04% fall in benchmark SENSEX. Pfizer Ltd has lost 0.1% over last one month compared to 3.16% gain in BSE Healthcare index and 3.28% drop in the SENSEX. On the BSE, 1 shares were traded in the counter so far compared with average daily volumes of 2724 shares in the past one month. The stock hit a record high of Rs 6452.85 on 02 Sep 2024. The stock hit a 52-week low of Rs 3742.9 on 07 Apr 2025.Powered by Capital Market - Live

Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on 21 July 2025.Powered by Capital Market - Live

BASF India Ltd, NLC India Ltd, Zensar Technologies Ltd, Newgen Software Technologies Ltd are among the other stocks to see a surge in volumes on NSE today, 20 May 2025.Pfizer Ltd witnessed volume of 12.07 lakh shares by 14:14 IST on NSE, a 75.73 times surge over two-week average daily volume of 15933 shares. The stock increased 10.90% to Rs.4,955.00. Volumes stood at 15028 shares in the last session.BASF India Ltd clocked volume of 7.26 lakh shares by 14:14 IST on NSE, a 15.18 times surge over two-week average daily volume of 47859 shares. The stock gained 8.17% to Rs.5,303.70. Volumes stood at 1.38 lakh shares in the last session.NLC India Ltd clocked volume of 167.99 lakh shares by 14:14 IST on NSE, a 14.61 times surge over two-week average daily volume of 11.50 lakh shares. The stock gained 2.14% to Rs.241.50. Volumes stood at 14.63 lakh shares in the last session.Zensar Technologies Ltd notched up volume of 131.18 lakh shares by 14:14 IST on NSE, a 13.13 fold spurt over two-week average daily volume of 9.99 lakh shares. The stock rose 6.37% to Rs.837.45. Volumes stood at 5.08 lakh shares in the last session.Newgen Software Technologies Ltd recorded volume of 57.45 lakh shares by 14:14 IST on NSE, a 10.05 times surge over two-week average daily volume of 5.72 lakh shares. The stock gained 9.64% to Rs.1,258.30. Volumes stood at 6.61 lakh shares in the last session.Powered by Capital Market - Live

Pfizer reported and exceptional profit of Rs 172.81 crore in Q4 March 2025, primarily due to the completion of the sale and transfer of its Thane facility to Zoetis Pharmaceutical Research. Sequentially, the company's adjusted net profit surged 55.43% while net sales jumped 10.02% in Q4 FY25 over Q3 FY25. Profit before tax and exceptional items stood at Rs 252.99 crore in Q4 FY25, up 3.74% year-on-year and up 46.71% QoQ. For the full year, adjusted net profit rose 17.28% to Rs 639.71 crore while net sales increased 4.02% to Rs 2,281.35 crore in the year ended March 2025 over the year ended March 2024. Profit before tax and exceptional items rose 14.25% year-on-year to Rs 843.28 crore in FY25 over FY24. The company's net cash from operating activities stood at Rs 659.75 crore in FY25, higher than Rs 256.84 crore in FY24. The company's board recommended a final dividend of Rs 35 per equity share, a special dividend of Rs 100 per equity share in view of 75th year of Pfizer in India and a special dividend of Rs 30 per equity share in view of the gain on transfer of assignment of leasehold land and building constructed on such land thereon, totaling to a dividend of Rs 165 per equity share for FY25. The company has fixed 9 July 2025, as the record date. Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Powered by Capital Market - Live

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May 2025, inter alia, have recommended the final dividend of Rs 35 per equity Share (i.e. 350%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May 2025, inter alia, have recommended the special dividend of Rs 100 per equity Share (i.e. 1000%) , subject to the approval of the shareholders.Powered by Capital Market - Live